Carofiglio, F.;                     Lopalco, A.;                     Lopedota, A.;                     Cutrignelli, A.;                     Nicolotti, O.;                     Denora, N.;                     Stefanachi, A.;                     Leonetti, F.    
        Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. Int. J. Mol. Sci. 2020, 21, 4469.
    https://doi.org/10.3390/ijms21124469
    AMA Style
    
                                Carofiglio F,                                 Lopalco A,                                 Lopedota A,                                 Cutrignelli A,                                 Nicolotti O,                                 Denora N,                                 Stefanachi A,                                 Leonetti F.        
                Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. International Journal of Molecular Sciences. 2020; 21(12):4469.
        https://doi.org/10.3390/ijms21124469
    
    Chicago/Turabian Style
    
                                Carofiglio, Francesca,                                 Antonio Lopalco,                                 Angela Lopedota,                                 Annalisa Cutrignelli,                                 Orazio Nicolotti,                                 Nunzio Denora,                                 Angela Stefanachi,                                 and Francesco Leonetti.        
                2020. "Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML" International Journal of Molecular Sciences 21, no. 12: 4469.
        https://doi.org/10.3390/ijms21124469
    
    APA Style
    
                                Carofiglio, F.,                                 Lopalco, A.,                                 Lopedota, A.,                                 Cutrignelli, A.,                                 Nicolotti, O.,                                 Denora, N.,                                 Stefanachi, A.,                                 & Leonetti, F.        
        
        (2020). Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML. International Journal of Molecular Sciences, 21(12), 4469.
        https://doi.org/10.3390/ijms21124469